Fundraising FoxBioTrack Capital
Venture capitalShanghai · Pre-Seed–Series A · 7 people tracked
Also known as BIOTRACK FUND II GP LIMITED
Find your way into BioTrack Capital
Sign up to see every warm intro you have to BioTrack Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BioTrack Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
BioTrack focuses on early-stage biotech, medtech, and cross-disciplinary healthcare sectors such as AI-driven and digital healthcare and consumer healthcare. The firm acts both as an investor and a long-term partner to entrepreneurs, leveraging an investment team with combined expertise in R&D, clinical operations, consulting, and investing. As an entrepreneur-founded VC, BioTrack emphasizes an extensive industry ecosystem of global biopharma, medtech, and healthcare conglomerates that provide deep insights, value-added services, and support for portfolio companies pursuing overseas and global expansion.
Source: firm website, verified Oct 1, 2026.
Team · 7 people
from the firm's website & public directories
What they invest in
from 4 of 12 portfolio companiesBiotech ×4Healthtech ×3Deep Tech ×2AI & Machine Learning ×1Medical Devices ×1
HQs:United States×2China×1
Investments · 12 tracked
founders shown can be your intro pathBy year:2025 · 12021 · 12 dated
Asieris Pharmaceuticals develops and commercializes drugs and diagnostic devices focused on cancer and other therapeutic areas, including treatments for advanced solid tumors and urological conditions.
BiotechHealthtechMedical Devices
EdiGene is a biotechnology company developing genome-editing-based therapies, including allogeneic cell therapies and in vivo RNA base editing platforms, alongside a high-throughput genome editing screening platform.
BiotechDeep TechHealthtech
Co-investorsLAVLilly Asia VenturesWI Harper Group3H Health InvestmentAlwin CapitalIDG Capital+2 more
Developing novel KRAS degraders.
Burlington, US
Huaixiang Hao(Founder)in
Co-investorsMRL Ventures FundJJDC
Rapafusyn develops molecular glue therapeutics using its RapaGlue platform of non-degrading macrocyclic compounds designed to modulate hard-to-drug intracellular and transmembrane protein targets.
AI & Machine LearningBiotechDeep TechBaltimore, US
Jun O. Liu(Founder)
Co-investors3E Bioventures Capital
TYK Medicines (同源康) is a Chinese biopharmaceutical company focused on discovering and developing innovative small-molecule drugs, with a platform for designing and screening targeted-therapy compounds.
BiotechHealthtech
Co-investorsAddor Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
BionovaGenor BiopharmaHaihe BiopharmaInnogenLigatechOBiOOnCusp
Portfolio news
latest coverage across their companiesRapafusyn · prnewswire.com · Sep 2, 2026
PAQ Therapeutics · finsmes.com · Jan 26, 2026
Frequently asked questions
- How many investments has BioTrack Capital made?
- BioTrack Capital has 12 tracked investments, including 1 dated in the last 24 months.
- What stage does BioTrack Capital invest at?
- BioTrack Capital invests at the Pre-Seed, Seed, Series A stages.
- What sectors does BioTrack Capital focus on?
- BioTrack Capital focuses on AI & Machine Learning, Biotech, Consumer, Digital Health, Healthtech, Medical Devices.
- Where is BioTrack Capital located?
- BioTrack Capital is headquartered in Shanghai, CN.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
Menlo Ventures is an early-stage venture capital firm backing transformative technology companies, with a strong current emphasis on artificial intelligence across enterprise, healthcare, and consumer markets.